Inhibition of tumor growth and metastasis by EMMPRIN multiple antigenic peptide (MAP) vaccination is mediated by immune modulation.

Simanovich, Elina; Brod, Vera; Rahat, Maya M; Drazdov, Ella; Walter, Miriam; Shakya, Jivan; Rahat, Michal A

Simanovich, Elina; Brod, Vera; Rahat, Maya M; Drazdov, Ella; Walter, Miriam; Shakya, Jivan; Rahat, Michal A.

Afiliación

Simanovich E; Immunotherapy Lab, Carmel Medical Center, Haifa, Israel; The Ruth and Bruce Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel.
Brod V; Immunotherapy Lab, Carmel Medical Center , Haifa, Israel.
Rahat MM; Immunotherapy Lab, Carmel Medical Center , Haifa, Israel.
Drazdov E; Immunotherapy Lab, Carmel Medical Center , Haifa, Israel.
Walter M; Immunotherapy Lab, Carmel Medical Center , Haifa, Israel.
Shakya J; Immunotherapy Lab, Carmel Medical Center , Haifa, Israel.
Rahat MA; Immunotherapy Lab, Carmel Medical Center, Haifa, Israel; The Ruth and Bruce Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel.

Oncoimmunology ; 6(1): e1261778, 2017.

Article en En | MEDLINE | ID: mdl-28197388

Palabras clave

Active peptide vaccination; EMMPRIN/CD147; angiogenesis; multiple antigenic peptide (MAP); tumor cellmacrophage interactions; tumor microenvironment

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Oncoimmunology Año: 2017 Tipo del documento: Article País de afiliación: Israel Pais de publicación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google